Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts

Published: 6 September 2021| Version 1 | DOI: 10.17632/w4478kftkk.1
Contributor:
Vartan Pahalyants

Description

Supplemental materials for the manuscript titled, "Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts," published in the Journal of the American Academy of Dermatology. Vartan Pahalyants MD, MBA1,2*, William S. Murphy MD, MBA1*, Nikolai Klebanov MD1, Chenyue Lu MBI1, Nicholas Theodosakis MD1, R. Monina Klevens DDS3, Hossein Estir PhD4,5, Evelyn Lilly MD1, Maryam Asgari MD1, Yevgeniy R. Semenov MD, MA1 1Massachusetts General Hospital, Department of Dermatology, Boston, MA 2Brigham and Women’s Hospital, Department of Medicine, Boston, MA 3Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences, Boston, MA 4Laboratory of Computer Science, Massachusetts General Hospital, Boston, MA 5Department of Medicine, Massachusetts General Hospital, Boston, MA * Designates co-first authors The supplement includes detailed methods, the study flow diagram, as well as supplemental analyses not included in the published manuscript.

Files